Despite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.

by Darlene Dobkowski

Combination of targeted therapy and chemotherapy prolongs survival in lung cancer, and FDA approves a chemotherapy-releasing device to treat bladder cancer.

by Thomas Celona

About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.

by Laura Gesualdi Gilmore

Rising prostate cancer rates reignite questions about screening guidelines, and a government report describing the health risks of alcohol may never be published.

by Eric Fitzsimmons

Some people’s cancer treatment may not align with their care goals, and a blood test may detect ovarian cancer at early stages.

by Darlene Dobkowski

A chemotherapy-releasing device helps destroy bladder cancer tumors, and long-distance running linked to increased risk for precancerous polyps.

by Thomas Celona

A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.

by Kyle Bagenstose

Some women over 70 may not need chemotherapy for high-risk breast cancer, and an early trial finds a pancreatic cancer vaccine can trigger an immune response.

by Marci A. Landsmann

Preliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.

by Sandra Gordon

A targeted therapy offers new treatment for a deadly brain cancer that mainly affects children, and more people in their 40s are getting screened for colorectal cancer.

by Marci A. Landsmann